Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR/ARHP Annual Scientific Meeting Plenary Highlights Targets and Treatments for Several Diseases

Vanessa Caceres  |  April 6, 2012

Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.

Treatment Patterns and Trends for Spondylarthropathies

Vanessa Caceres  |  April 6, 2012

Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.

Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk

Kathleen Louden  |  April 6, 2012

Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.

Pinpoint Cognitive Dysfunction in Patients with Lupus

Vanessa Caceres  |  April 6, 2012

More than 80% of SLE patients experience some type of neurologic manifestation during their disease course. The challenge for rheumatologists and other clinicians lies in appropriately diagnosing any cognitive dysfunctions that accompany lupus and better understanding the causes and risk factors of those dysfunctions. “Cognitive Function in SLE” was the focus of a talk at the 2011 ACR/ARHP Annual Scientific Meeting in November.

Ethics Forum: The Ethical Pitfalls of Clinical Trials

Robert H. Shmerling, MD  |  April 6, 2012

Your patient is deciding whether to enroll in a clinical trial at your institution and wants your advice about whether to participate.

Ethics Forum: Letters from Our Readers—Accepting Gifts

Ines Colmegna, MD  |  April 6, 2012

We received a few letters in response to the December 2011 Ethics Forum, which asked the question: What is your personal policy about accepting gifts?

Terminate Staff with Caution

Steven M. Harris, Esq.  |  April 6, 2012

Key principles that will help facilitate terminations that bring cost-effective finality to the employment relationship.

Letter: Another Thinking Discipline

Walter Doege, MD  |  April 6, 2012

I read today the article “How a Rheumatologist Thinks” and I want to say that is one of the most interesting articles I’ve read about clinical medicine.

Letter: Thanks and Farewell

John Luetkemeyer, MD  |  April 6, 2012

Dr. Pisetsky, I want to personally thank you for the time spent by you as editor of The Rheumatologist.

ACR Coding Specialist Responds to Letter: Of Coding and Perception

Melesia R. Tillman, CPC-I, CRHC, CHA  |  April 6, 2012

Thank you for forwarding this concern; feedback on the “Coding Corners” is greatly appreciated. I would like to discuss each issue line by line.

  • « Previous Page
  • 1
  • …
  • 694
  • 695
  • 696
  • 697
  • 698
  • …
  • 821
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences